Open access · OA
via OpenAlex
Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial
Valesca Dall’Alba, Flávia Moraes Silva, Juliana Peçanha Antonio, Thaís Steemburgo, Caroline Persch Royer, Jussara Carnevale de Almeida, Jorge Luiz Gross, Mirela Jobim de Azevedo
British Journal Of Nutrition · 2013 · ▲ 126 citations
Abstract
A diet rich in fibre seems to protect against the metabolic syndrome (MetS), but there is scarce information about the role of fibre intake in patients with the MetS and diabetes. The aim of the present study was to evaluate the effects of soluble fibre from partially hydrolysed guar gum (PHGG) on the MetS and cardiovascular risk factors in patients with type 2 diabetes. In the present randomised controlled clinical trial, forty-four patients with type 2 diabetes (males 38·6 %, age 62 (SD 9) years, diabetes duration 14·2 (SD 9·6) years) and the MetS underwent clinical, laboratory and dietary evaluations at baseline, 4 and 6 weeks. All patients followed their usual diet and the intervention group (n 23) received an additional 10 g/d of PHGG. In the intervention group, waist circumference (WC), glycated Hb (HbA1c), 24 h urinary albumin excretion (UAE) and serum trans-fatty acids (FA) were reduced in comparison with baseline after 4 and 6 weeks: WC 103·5 (SD 9·5) to 102·1 (SD 10) to 102·3 (SD 9·7) cm; HbA1c 6·88 (SD 0·99) to 6·64 (SD 0·94) to 6·57 (SD 0·84) %; 24 h UAE 6·8 (interquartile range 3·0-17·5) to 4·5 (interquartile range 3·0-10·5) to 6·2 (interquartile range 3·0-9·5) mg; trans-FA 71 (interquartile range 46-137) to 67 (interquartile range 48-98) to 57 (interquartile range 30-110) mg/l (P< 0·05 for all). The only change in the control group was weight reduction: 77·0 (SD 13·5) to 76·2 (SD 13·3) to 76·1 (SD 13·4) kg (P= 0·005). Other MetS components (blood pressure, TAG, HDL-cholesterol, fasting plasma glucose), total and LDL-cholesterol, C-reactive protein and endothelin-1 did not change in either group. In patients with type 2 diabetes and the MetS, the addition of PHGG to the usual diet improved cardiovascular and metabolic profiles by reducing WC, HbA1c, UAE and trans-FA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1017/s0007114513001025
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Dall’Alba, V., Silva, F.M., Antonio, J.P., Steemburgo, T., Royer, C.P., Almeida, J.C.D., Gross, J.L., & Azevedo, M.J.D. (2013). Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial. <em>British Journal Of Nutrition</em>. https://doi.org/10.1017/s0007114513001025
Vancouver
Dall’Alba V, Silva FM, Antonio JP, Steemburgo T, Royer CP, Almeida JCD, et al. Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial. British Journal Of Nutrition. 2013. doi:10.1017/s0007114513001025.
BibTeX
@article{valesca2013Improv,
title = {Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial},
author = {Valesca Dall’Alba and Flávia Moraes Silva and Juliana Peçanha Antonio and Thaís Steemburgo and Caroline Persch Royer and Jussara Carnevale de Almeida and Jorge Luiz Gross and Mirela Jobim de Azevedo},
journal = {British Journal Of Nutrition},
year = {2013},
doi = {10.1017/s0007114513001025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrition & Metabolism 2021
Open access · CC-BY
Time-restricted feeding improves blood glucose and insulin sensitivity in overweight patients with type 2 diabetes: a randomised controlled trial
Journal of the Endocrine Society 2025
Open access · CC-BY
OR19-08 Intermittent versus Time-Restricted or Continuous Calorie Restriction for the Management of Obesity with Type 2 Diabetes: A Randomized Clinical Trial
BMJ Open 2022
Open access · CC-BY
Efficacy of time-restricted eating and behavioural economic interventions in reducing fasting plasma glucose, HbA1c and cardiometabolic risk factors compared with time-restricted eating alone or usual care in patients with impaired fasting glucose: protocol for an open-label randomised controlled trial
Medical Journal of the Chinese People's Armed Police Forces 2006
Citation only
Metabolic impact of body weight variation on old age type 2 diabetes mellitus
Obesity Facts 2012
Citation only
The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
Cardiovascular Diabetology 2011
Open access · CC-BY